购物车
- 全部删除
- 您的购物车当前为空
Anticanceragent 235,即Compound 49,通过调节PI3K/AKT/mTOR信号通路作用,增加活性氧(ROS)生成,降低线粒体膜电位,从而有效抑制HCT116、Caco-2、AGS和SMMC-772种癌细胞的增殖(IC50为0.35-26.9 μM)。此外,该化合物在G2/M期阻滞细胞周期,诱导HCT-116细胞发生凋亡(apoptosis)。
Anticanceragent 235,即Compound 49,通过调节PI3K/AKT/mTOR信号通路作用,增加活性氧(ROS)生成,降低线粒体膜电位,从而有效抑制HCT116、Caco-2、AGS和SMMC-772种癌细胞的增殖(IC50为0.35-26.9 μM)。此外,该化合物在G2/M期阻滞细胞周期,诱导HCT-116细胞发生凋亡(apoptosis)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | Anticanceragent 235 (Compound 49) functions as a modulator of the PI3K/AKT/mTOR signaling pathway, enhancing reactive oxygen species (ROS) production and reducing mitochondrial membrane potential, thereby inhibiting the proliferation of cancer cell lines HCT116, Caco-2, AGS, and SMMC-772 with IC50 values ranging from 0.35 to 26.9 μM. Additionally, it induces apoptosis and causes cell cycle arrest at the G2/M phase in HCT-116 cells. |
分子量 | 296.75 |
分子式 | C17H13ClN2O |
CAS No. | 2411108-21-7 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.